ProfileGDS4459 / ENSG00000136935
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 54% 71% 72% 53% 70% 70% 65% 77% 75% 69% 77% 72% 68% 67% 72% 58% 69% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.5654
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.2871
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.5672
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.5953
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3570
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.2670
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.1565
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.9377
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.7775
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.3169
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.8277
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.5672
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2568
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0567
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.5472
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.6658
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.1469